Related Experiment Videos
[Allergic bronchial asthma caused by bromelin]
G Gailhofer1, I Teubl, M Wilders-Truschnig
1Universitätsklinik für Dermatologie und Venerologie, Graz, Osterreich.
Dermatosen in Beruf Und Umwelt. Occupation and Environment
|September 1, 1987
Summary
Occupational allergy to bromelain, a proteolytic enzyme from Bromeliaceae, often causes respiratory issues like allergic bronchial asthma. Sensitization typically occurs through inhalation, not ingestion, highlighting workplace safety needs.
Area of Science:
- Biochemistry
- Occupational Health
- Allergology
Background:
- Bromelain, a group of proteolytic enzymes derived from Bromeliaceae plants, possesses widespread applications.
- These enzymes are utilized across pharmaceutical industries, food production, and diagnostic laboratories.
- Understanding the occupational health risks associated with bromelain exposure is crucial.
Observation:
- Two cases of occupational allergy to bromelain were documented.
- The primary manifestation observed was respiratory, specifically allergic bronchial asthma.
- The clinical presentation suggests a strong link between bromelain exposure and respiratory symptoms.
Findings:
- Occupational sensitization to bromelain predominantly occurs via inhalation of airborne particles.
- Ingestion of bromelain is less likely to cause sensitization compared to inhalation.
- Respiratory exposure is the primary route for developing bromelain allergy.
Implications:
- Healthcare providers should consider bromelain allergy in patients with occupational asthma, especially those in relevant industries.
- Implementing stringent inhalation exposure controls in workplaces handling bromelain is recommended.
- Further research into the immunological mechanisms of bromelain sensitization via inhalation is warranted.